BioElectronics has run out of options after 22-years. Sales-Track showing 2025 sales in serious decline. The resources needed for BIEL to operate have vanished. The procurement requirements management demands on distributors show the company has zero existing infrastructure.
Thus with these conditions BioElectronics was and is doomed to the current sales levels.